Older patients with schizophrenia: Challenges in the coming decades

Psychiatric Services

Volumn 50, Issue 9, 1999, Pages 1178-1183

  Palmer, Barton W ^a,b   Heaton, Shelley C ^a   Jeste, Dilip V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; SEROTONIN ANTAGONIST;

AGING; ARTICLE; BEHAVIOR THERAPY; COGNITIVE THERAPY; ELDERLY CARE; EXTRAPYRAMIDAL SYMPTOM; HEALTH CARE COST; HUMAN; ONSET AGE; PREVALENCE; PRIMARY PREVENTION; PSYCHOSOCIAL CARE; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

EID: 0032859549     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.50.9.1178     Document Type: Article

References (64)

1. Hobbs FB, Damon BL (eds): 65+ in the United States. Washington DC, US Bureau of the Census, 1996
2. Caldwell CB, Gottesman II: Schizophrenics kill themselves too: a review of risk factors for suicide. Schizophrenia Bulletin 16: 571-589, 1990
3. Meltzer HY: Suicide in schizophrenia: risk factors and clozapine treatment. Journal of Clinical Psychiatry 59(suppl 3):15-20, 1998
4. Jeste DV: Growing disparity between need and reality: research in geriatric psychiatry. Current Opinion in Psychiatry 9:279-280, 1996
5. Jeste DV, Alexopoulous GS, Bartels SJ, et al: Consensus statement on the upcoming crisis in geriatric mental health: research agenda for the next two decades. Archives of General Psychiatry, in press
6. Harris MJ, Jeste DV: Late-onset schizophrenia: an overview. Schizophrenia Bulletin 14:39-55, 1988
7. Robins LN, Regier DA (eds): Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York, Free Press, 1991
8. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. Washington, DC, American Psychiatric Association, 1980
9. Rabins PV, Black B, German P, et al: The prevalence of psychiatric disorders in elderly residents of public housing. Journal of Gerontology: Medical Sciences 51A:M319-324, 1996
10. Kraepelin: Dementia Praecox and Paraphrenia, 1919. Translated by Barclay RM. Huntington, NY, Krieger, 1971
11. Davidson M, Harvey PD, Powchik P, et al: Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. American Journal of Psychiatry 152:197-207, 1995
12. Cohen CI: Outcome of schizophrenia into later life: an overview. Gerontologist 30: 790-797, 1990
13. Bleuler M: The Schizophrenic Disorders: Long-Term Patient and Family Studies. Translated by Clemens SM. New Haven, Conn, Yale University Press, 1978
14. Ciompi L: Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophrenia Bulletin 6:606-618, 1980
15. Harding CM, Brooks GW, Ashikaga T, et al: The Vermont longitudinal study: II. long-term outcome of subjects who once met the criteria for DSM-III schizophrenia. American Journal of Psychiatry 144:727-735, 1987
16. Jeste DV, Symonds LL, Harris MJ, et al: Non-dementia non-praecox dementia praecox? Late-onset schizophrenia. American Journal of Geriatric Psychiatry 5:302-317, 1997
17. Gross G, Huber G, Schuttler R: Long-term course of Schneiderian schizophrenia, in Schizoaffective Psychoses. Edited by Marneros A, Tsuang MT. Berlin, Springer-Verlag, 1986
18. Nasar SA: A Beautiful Mind. New York, Simon & Schuster, 1998
19. Arranz B, Blennow K, Ekman R, et al: Brain monoaminergic and neuropeptidergic variations in human aging. Journal of Neural Transmission 103:101-115, 1996
20. Ram R, Bromet EJ, Eaton WW, et al: The natural course of schizophrenia: a review of first-admission studies. Schizophrenia Bulletin 18:185-207, 1992
21. Mental Disorders: Glossary and Guide to Their Classification in Accordance With the Ninth Revision of the International Classification of Diseases. Geneva, World Health Organization, 1978
22. Wyatt RJ: Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin 17:325-351, 1991
23. Feighner JP, Robins E, Guze SB, et al: Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry 26: 57-63, 1972
24. Fish F: Senile schizophrenia. Journal of Mental Science 106:938-946, 1960
25. Rabins P, Pauker S, Thomas J: Can schizophrenia begin after age 44? Comprehensive Psychiatry 25:290-293, 1984
26. Gold DD Jr: Late age of onset schizophrenia: present but unaccounted for. Comprehensive Psychiatry 25:225-237, 1984
27. Essa M: Late-onset schizophrenia (ltr). American Journal of Psychiatry 139:1528, 1982
28. Harris MJ, Cullum CM, Jeste DV: Clinical presentation of late-onset schizophrenia. Journal of Clinical Psychiatry 49:356-360, 1988
29. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed, rev. Washington, DC, American Psychiatric Association, 1987
30. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994
31. Murray RM, O'Callaghan E, Castle DJ, et al: A neurodevelopmental approach to the classification of schizophrenia. Schizophrenia Bulletin 18:319-332, 1992
32. Miller BL, Lesser IM, Boone KB, et al: Brain lesions and cognitive function in late-life psychosis. British Journal of Psychiatry 158:76-82, 1991
33. Roth M: Interaction of genetic and environmental factors in the causation of schizophrenia, in Schizophrenia: Somatic Aspects. Edited by Richter D. New York, Pergamon, 1957
34. Cooper AF, Curry AR, Kay DWK, et al: Hearing loss in paranoid and affective psychoses of the elderly. Lancet 2:851-854, 1974
35. Varner RV, Gaitz CM: Schizophrenic and paranoid disorders in the aged. Psychiatric Clinics of North America 5:107-118, 1982
36. Lohr J, Alder M, Flynn K, et al: Minor physical anomalies in older patients with late-onset schizophrenia, early-onset schizophrenia, depression, and Alzheimer's disease. American Journal of Geriatric Psychiatry 5:318-323, 1997
37. Corey-Bloom J, Jernigan T, Archibald S, et al: Quantitative magnetic resonance imaging in late-life schizophrenia. American Journal of Psychiatry 152:447-449, 1995
38. DeLisi LE: The significance of age of onset for schizophrenia. Schizophrenia Bulletin 18:209-215, 1992
39. Jeste DV, McAdams LA, Palmer BW, et al: Relationship of neuropsychological and MRI measures with age of onset of schizophrenia. Acta Psychiatrica Scandinavica 98:156-164, 1998
40. Jeste DV, Palmer BW, Harris MJ: Response to Almeida's "Early-versus late-onset schizophrenia: is it time to define the difference?" (ltr) American Journal of Geriatric Psychiatry 6:346-347, 1998
41. Wasylenki DA: The cost of schizophrenia. Canadian Journal of Psychiatry 39(9 suppl 2):S65-S69, 1994
42. Wyatt RJ, Henter I, Leary MC, et al: An economic evaluation ol schizophrenia, 1991. Social Psychiatry and Psychiatric Epidemiology 30:196-205, 1995
43. Cuffel BJ, Jeste DV, Halpain M, et al: Treatment costs and use of community mental health services for schizophrenia by age-cohorts. American Journal of Psychiatry 153:870-876, 1996
44. Population Projections of the United States by Age, Sex, Race, and Hispanic Origin: 1995 to 2050. Washington, DC, US Bureau of the Census, 1996
45. Patterson TL, Kaplan RM, Grant I, et al: Quality of well-being in late-life psychosis. Psychiatry Research 63:169-181, 1996
46. Jeste DV, Rockwell E, Harris MJ, et al: Conventional versus newer antipsychotics in elderly patients. American Journal of Geriatric Psychiatry 7:70-76, 1999
47. Kane JM, Woerner M, Lieherman J: Tardive dyskinesia: prevalence, incidence, and risk factors. Journal of Clinical Psychopharmacology 8(suppl 4):52S-56S, 1988
48. Kane JM, Honigfeld G, Singer J, et al: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Archives of General Psychiatry 45:789-796, 1988
49. Marder SR, Meibach RC: Risperidone in the treatment of schizophrenia. American Journal of Psychiatry 151:825-835, 1994
50. Meltzer HY, Fibiger HC: Olanzapine: a new atypical autipsychotic drug. Neuropsychopharmacology 14:83-85, 1996
51. Small JG, Hirsch SH, Arvanitis LA, et al: Qnetiapine in patients with schizophrenia. Archives of General Psychiatry 54:549-557, 1997
52. Thomas CS, Lewis CS: Which atypical antipsychotic (editl)? British Journal of Psychiatry 172:106-109, 1998
53. Glazer WM, Johnstone BM: Pharmacoeconomic evaluation of antipsychotic therapy for schizophrenia. Journal of Clinical Psychiatry 58(suppl 10):50-54, 1997
54. Keks NA: Impact of newer antipsychotics on outcomes in schizophrenia. Clinical Therapeutics 19:148-158, 1997
55. Droge JA, Billig N: Improving practicing physicians' knowledge of geriatric mental health issues. Family Medicine 24:158-160, 1992
56. Lebowitz BD, Rudorfer MV: Treatment research at the millennium: from efficacy to effectiveness (editl). Journal of Clinical Psychopharmacology 18:1, 1998
57. Patterson TL, Jeste DV: The potential impact of the baby-boom generation on substance abuse among elderly persons. Psychiatric Services 50:1184-1188, 1999
58. National Bioethics Advisory Commission: Research involving persons with mental disorders that may affect decision making capacity, 1999. Available at http://bioethics. gov/capacity/TOC.htm
59. Weiss R: Bioethics group divided over research on mentally ill. Washington Post, Nov 16, 1998, p A6
60. Rowe JW, Kahn RL: Successful aging. Gerontologist 37:433-440, 1997
61. Symonds LL, Gladsjo JA, Heaton RK, et al: Patterns of successful neurocognitive aging (abstr). Journal of the International Neuropsychological Society 4:72, 1998
62. Harris HW, Lebowitz BD: Clinically oriented basic science: emerging opportunities for research in late-life mental disorders (editl). American Journal of Geriatric Psychiatry 5:284-286, 1998
63. Hill D: Electroencephalogram in schizophrenia, in Schizophrenia: Somatic Aspects. Edited by Richter D. New York, Pergamon, 1957
64. Lindamer LA, Lohr JB, Harris MJ, et al: Gender, estrogen, and schizophrenia. Psychopharmacology Bulletin 33:221-228, 1997